Catalyst Wire Dossier Catalyst Wire Dossier

BD111

· Shanghai BDgene Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BD111, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis [Phase 1]

See pricing